Form 4: Barinthus Biotherapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Robin Wright, a Director of Barinthus Biotherapeutics plc., reported multiple transactions in common stock on September 9, 2026.
Summary
- Disposition to the issuer: disposed of 48,256 Ordinary Shares on September 9, 2026 (Direct).
- Disposition to the issuer: disposed of 20,394 Share Option (Right to Buy) on September 9, 2026 (Direct).
- Disposition to the issuer: disposed of 34,328 Share Option (Right to Buy) on September 9, 2026 (Direct).
- Disposition to the issuer: disposed of 18,604 Share Option (Right to Buy) on September 9, 2026 (Direct).
- Disposition to the issuer: disposed of 19,197 Share Option (Right to Buy) on September 9, 2026 (Direct).
- Disposition to the issuer: disposed of 19,516 Share Option (Right to Buy) on September 9, 2026 (Direct).
- Disposition to the issuer: disposed of 20,174 Share Option (Right to Buy) on September 9, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robin Wright — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-09 | Disposition to the issuer | Ordinary Shares | 48,256 | — | — | 0 |
| 2026-09-09 | Disposition to the issuer | Share Option (Right to Buy) | 20,394 | — | — | 0 |
| 2026-09-09 | Disposition to the issuer | Share Option (Right to Buy) | 34,328 | — | — | 0 |
| 2026-09-09 | Disposition to the issuer | Share Option (Right to Buy) | 18,604 | — | — | 0 |
| 2026-09-09 | Disposition to the issuer | Share Option (Right to Buy) | 19,197 | — | — | 0 |
| 2026-09-09 | Disposition to the issuer | Share Option (Right to Buy) | 19,516 | — | — | 0 |
| 2026-09-09 | Disposition to the issuer | Share Option (Right to Buy) | 20,174 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-09 | Disposition to the issuer (48,256 shares) |
| 2026-09-09 | Disposition to the issuer (20,394 shares) |
| 2026-09-09 | Disposition to the issuer (34,328 shares) |
| 2026-09-09 | Disposition to the issuer (18,604 shares) |
| 2026-09-09 | Disposition to the issuer (19,197 shares) |
| 2026-09-09 | Disposition to the issuer (19,516 shares) |
| 2026-09-09 | Disposition to the issuer (20,174 shares) |
Keywords
insider transaction, Form 4, BRNS, Barinthus Biotherapeutics plc., neutral, Robin Wright
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.